Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing

被引:19
|
作者
de Alencastro, Gustavo [1 ,2 ,3 ]
Pekrun, Katja [1 ,2 ]
Valdmanis, Paul [1 ,2 ,4 ]
Tiffany, Matthew [1 ,2 ,5 ]
Xu, Jianpeng [1 ,2 ]
Kay, Mark A. [1 ,2 ]
机构
[1] Stanford Univ, Dept Pediat, Sch Med, 269 Campus Dr, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA
[3] Sangamo Therapeut, Richmond, CA USA
[4] Univ Washington, Sch Med, Div Med Genet, Seattle, WA USA
[5] Denali Therapeut, San Francisco, CA USA
关键词
high-throughput sequencing; capsid evolution; AAV libraries; GROWTH-FACTOR RECEPTOR; GENE-TRANSFER; IN-VIVO; CORECEPTOR; SELECTION;
D O I
10.1089/hum.2019.339
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Despite early successes using recombinant adeno-associated virus (rAAV) vectors in clinical gene therapy trials, limitations remain making additional advancements a necessity. Some of the challenges include variable levels of pre-existing neutralizing antibodies and poor transduction in specific target tissues and/or diseases. In addition, readministration of an rAAV vector is in general not possible due to the immune response against the capsid. Recombinant adeno-associated virus (AAV) vectors with novel capsids can be isolated in nature or developed through different directed evolution strategies. However, in most cases, the process of AAV selection is not well understood and new strategies are required to define the best parameters to develop more efficient and functional rAAV capsids. Therefore, the use of barcoding for AAV capsid libraries, which can be screened by high-throughput sequencing, provides a powerful tool to track AAV capsid evolution and potentially improve AAV capsid library screens. In this study, we examined how different parameters affect the screen of two different AAV libraries in two human cell types. We uncovered new and unexpected insights in how to maximize the likelihood of obtaining AAV variants with the desired properties. The major findings of the study are the following. (1) Inclusion of helper-virus for AAV replication can selectively propagate variants that can replicate to higher titers, but are not necessarily better at transduction. (2) Competition between AAVs with specific capsids can take place in cells that have been infected with different AAVs. (3) The use of low multiplicity of infections for infection results in more variation between screens and is not optimal at selecting the most desired capsids. (4) Using multiple rounds of selection can be counterproductive. We conclude that each of these parameters should be taken into consideration when screening AAV libraries for enhanced properties of interest.
引用
收藏
页码:553 / 564
页数:12
相关论文
共 50 条
  • [21] Surface loop dynamics in adeno-associated virus capsid assembly
    DiPritmio, Nina
    Asokan, Aravind
    Govindasamy, Lakshmanan
    Agbandje-McKenna, Mavis
    Samulski, R. Jude
    JOURNAL OF VIROLOGY, 2008, 82 (11) : 5178 - 5189
  • [22] Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens
    Nicolson, Sarah C.
    Li, Chengwen
    Hirsch, Matthew L.
    Setola, Vincent
    Samulski, R. Jude
    JOURNAL OF VIROLOGY, 2016, 90 (16) : 7019 - 7031
  • [23] High-Throughput Small Molecule Screen Yields Novel Classes of Compounds That Modulate Adeno-Associated Virus Transduction
    Nicolson, Sarah C.
    Samulski, R. Jude
    MOLECULAR THERAPY, 2012, 20 : S45 - S45
  • [24] Nuclear transport of the major capsid protein is essential for adeno-associated virus capsid formation
    Hoque, M
    Ishizu, K
    Matsumoto, A
    Han, S
    Arisaka, F
    Takayama, M
    Suzuki, K
    Kato, K
    Kanda, T
    Watanabe, H
    Handa, H
    JOURNAL OF VIROLOGY, 1999, 73 (09) : 7912 - 7915
  • [25] Modifying immune responses to adeno-associated virus vectors by capsid engineering
    Bentler, Martin
    Hardet, Romain
    Ertelt, Moritz
    Rudolf, Daniela
    Kaniowska, Dorota
    Schneider, Andreas
    Vondran, Florian W. R.
    Schoeder, Clara T.
    Delphin, Marion
    Lucifora, Julie
    Ott, Michael
    Hacker, Ulrich T.
    Adriouch, Sahil
    Buening, Hildegard
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2023, 30 : 576 - 592
  • [26] Chemical modification of the adeno-associated virus capsid to improve gene delivery
    Mevel, Mathieu
    Bouzelha, Mohammed
    Leray, Aurelien
    Pacouret, Simon
    Guilbaud, Mickael
    Penaud-Budloo, Magalie
    Alvarez-Dorta, Dimitri
    Dubreil, Laurence
    Gouin, Sebastien G.
    Combal, Jean Philippe
    Hommel, Mirja
    Gonzalez-Aseguinolaza, Gloria
    Blouin, Veronique
    Moullier, Philippe
    Adjali, Oumeya
    Deniaud, David
    Ayuso, Eduard
    CHEMICAL SCIENCE, 2020, 11 (04) : 1122 - 1131
  • [27] Adeno-associated virus capsid antigen presentation is dependent on endosomal escape
    Li, Chengwen
    He, Yi
    Nicolson, Sarah
    Hirsch, Matt
    Weinberg, Marc S.
    Zhang, Ping
    Kafri, Tal
    Samulski, R. Jude
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (03): : 1390 - 1401
  • [28] Capsid modification of adeno-associated virus and tumor targeting gene therapy
    XU ZengHui1
    2 Laboratory of Gene and Viral Therapy
    ChineseScienceBulletin, 2008, (24) : 3790 - 3797
  • [29] Probing Capsid Mosaics Formation in Adeno-Associated Virus Library Preparations
    Pacouret, Simon
    Telford, Elizabeth
    Nicolaou, Fotini
    Andres-Mateos, Eva
    Xiao, Ru
    Ayuso, Eduard
    Vandenberghe, Luk H.
    MOLECULAR THERAPY, 2018, 26 (05) : 167 - 167
  • [30] Capsid modification of adeno-associated virus and tumor targeting gene therapy
    Xu ZengHui
    Zhou XiuMei
    Shi WenFang
    Qian Qijun
    CHINESE SCIENCE BULLETIN, 2008, 53 (24): : 3790 - 3797